science

A sleight of hand occurred at the Department of Justice as drama was unfolding in the Senate over Todd Blanche’s confirmation for attorney general.

Even by the standards of this White House, last week was a lot. On Monday, President Donald Trump announced 50% tariffs on Canadian goods via a Depression-era statute that has never been used (and might be defunct). On Tuesday, he set a 100% tariff on generic drugs but delayed it until 2028. His tea

Braveheart Bio Inc., a clinical-stage biopharmaceutical company backed by a16z, is seeking to raise as much as $318.8 million in an initial public offering, adding to a growing pipeline of listings in the sector.

Even by the standards of this White House, last week was a lot. On Monday, President Donald Trump announced 50% tariffs on Canadian goods via a Depression-era statute that has never been used (and might be defunct). On Tuesday, he set a 100% tariff on generic drugs but delayed it until 2028. His tea

AT&T, Verizon slip on report SpaceX looking to acquire competitors, compete in auction

Attovia Therapeutics Inc., an early-stage drug developer focused on immune-mediated diseases with high unmet need, is seeking to raise as much as $212.5 million in a US initial public offering.

AT&T, Verizon slip on report SpaceX looking to acquire competitors, compete in auction

The Bio-Pharma Industry and Society Listing Summary Please join the CSIS Global Health Policy Center on March 17, from 10:00am – 11:30am, for an exploration of how private bio-pharmaceutical firms can better support the critically important societal goals of improved affordability, access, quality,

UK drugmaker bets new site in university city will bolster pipelines of medicines

El Niño could push global temperatures past 2C in early 2027, raising significant climate change concerns, researchers warn.